Octreotide Impurity 4 is a defined analogue that differs subtly from octreotide in residue composition or cyclization pattern. Such changes modify conformation, polarity, and chromatographic characteristics. Researchers use it as a marker in impurity panels and degradation studies. Applications include analytical-method validation, process monitoring, and structure-stability correlations.
CAT No: R2761
Synonyms/Alias:(4R,7S,10S,13S,16R)-16-((R)-2-Amino-3-phenylpropanamido)-10-(4-aminobutyl)-13-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamide
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More